Slate Path Capital LP - Q1 2022 holdings

$1.95 Billion is the total value of Slate Path Capital LP's 43 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 100.0% .

 Value Shares↓ Weighting
PAAS BuyPAN AMERN SILVER CORP$106,142,000
+23.3%
3,888,000
+12.8%
5.44%
+20.5%
BuyWEWORK INCcl a$99,299,000
+566.4%
14,560,000
+740.3%
5.08%
+551.1%
X BuyUNITED STATES STL CORP NEW$98,501,000
+79.9%
2,610,000
+13.5%
5.04%
+75.7%
GDXJ BuyVANECK ETF TRUSTjunior gold mine$69,133,000
+226.5%
1,475,000
+192.1%
3.54%
+218.9%
OPEN BuyOPENDOOR TECHNOLOGIES INC$67,730,000
-31.4%
7,830,000
+15.8%
3.47%
-33.0%
NOV NewNOV INC$63,242,0003,225,000
+100.0%
3.24%
RIG NewTRANSOCEAN LTD$61,304,00013,414,545
+100.0%
3.14%
BuyCIVITAS RESOURCES INC$59,292,000
+214.5%
993,000
+157.9%
3.04%
+207.3%
EQT BuyEQT CORP$51,271,000
+126.0%
1,490,000
+43.3%
2.63%
+120.9%
OVV NewOVINTIV INC$50,555,000935,000
+100.0%
2.59%
PAGS NewPAGSEGURO DIGITAL LTD$30,576,0001,525,000
+100.0%
1.57%
CRC NewCALIFORNIA RES CORP$24,154,000540,000
+100.0%
1.24%
STNE NewSTONECO LTD$8,717,000745,000
+100.0%
0.45%
EIGR NewEIGER BIOPHARMACEUTICALS INC$2,117,000255,000
+100.0%
0.11%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARTER COMMUNICATIONS INC N30Q3 202315.2%
ALNYLAM PHARMACEUTICALS INC30Q3 20208.9%
UNITED STATES STL CORP NEW24Q3 202311.4%
NEW YORK TIMES CO23Q3 202310.9%
VANECK VECTORS ETF TR21Q3 202319.5%
PAN AMERN SILVER CORP21Q3 20237.6%
CUE BIOPHARMA INC17Q3 20231.3%
BARRICK GOLD CORPORATION16Q4 202015.7%
MOSAIC CO NEW15Q4 202116.8%
MEDICINES CO15Q4 201912.2%

View Slate Path Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Slate Path Capital LP Q1 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cue Biopharma, Inc.February 14, 20232,402,4555.6%
Stitch Fix, Inc.February 14, 2023? ?
Cyclerion Therapeutics, Inc.January 13, 20237,157,60116.5%
Zimmer Energy Transition Acquisition Corp.February 14, 20222,000,0005.8%
5:01 Acquisition Corp.February 11, 2022500,0005.8%
Hippo Holdings Inc.February 11, 2022350,0000.1%
Warner Music Group Corp.February 11, 20223,134,7792.6%
Reinvent Technology Partners ZFebruary 16, 20211,750,0007.6%

View Slate Path Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-01-22
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G2023-02-14
13F-HR2023-02-14
SC 13G2023-01-13
SC 13G2022-11-18

View Slate Path Capital LP's complete filings history.

Compare quarters

Export Slate Path Capital LP's holdings